News

April 23 – The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.”  Mr. Weinberg presented on the mandatory need for audits and audit independence.  A full copy of his presentation can be found here.                 For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos, Vice President, at jeff.antos@weinberggroup.com or 202.280.0815.   read more

Linking Leaders’ Clinical Quality roundtable series provides pharmaceutical and biotech executives a forum to share insights and experiences, benchmark progress, and collaborate on solutions with like-minded peers facing similar industry obstacles in a closed-door, invitation-only setting. This unique forum brings together an exclusive community of executives engaged in Clinical Quality Assurance, Compliance, Risk Management and more to discuss collective challenges and collaborate on new ways to spearhead innovation in executing quality in clinical trials. The Weinberg Group is sponsoring the 2012 quarterly roundtable meetings with Amy Hansen, Director of GCP Services, joining the pharma executive network members at the boardroom table. For more information please visit www.linkingleaders.com. read more

The Weinberg Group is excited to announce the publication of its new blog, Weinberg on FDA.  The blog will act as a forum for discussion among our experienced consultants and the regulatory community.  Each week, Weinberg on FDA will feature opinions and discussion on FDA news and regulatory decisions from some of our most senior consultants, including Nick Fleischer, Joel Falk and Bob Roth. As we continue to provide clients with exceptional service and results, we believe this blog will allow the public to become familiar with The Weinberg Group, our knowledge and our work.  We have also joined the discussion on Facebook and Twitter and look forward to sharing company activities, announcements and thoughts with our followers on a daily basis. Weinberg on FDA Twitter Facebook   read more